Turtle Cameron

Chief Executive Officer

Turtle Cameron has filed 12 SEC Form 4 filings (40 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Oct 3, 2026.

On the most recent filing, Turtle Cameron is listed as Chief Executive Officer at Spyre Therapeutics, Inc. Inside the rolling window, Turtle Cameron reported no open-market purchases and 12 open-market sales totaling $11.4M in SYRE. The largest disclosed transaction in the window is a sale of 15,000 SYRE shares on Aug 3, 2026, worth $1.4M.

Companies traded

Other insiders at SYRE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$11.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
SYRESale$1.4MOct 3SEC ↗
SYRESale$1.3MSep 4SEC ↗
SYRESale$1.4MAug 6SEC ↗
SYRESale$1.3MJul 3SEC ↗
SYRESale$1.1MJun 4SEC ↗
SYRESale$1.1MMay 2SEC ↗
SYRESale$740KApr 3SEC ↗
SYRESale$633KMar 3SEC ↗
SYRESale$492KFeb 4SEC ↗
SYRESale$460KJan 6SEC ↗
SYRESale$435KDec 3SEC ↗
SYRESale$1.0MNov 5SEC ↗
Showing 1–12 of 12
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Turtle Cameron made?

Turtle Cameron has filed 12 SEC Form 4 filings (40 transaction rows) across 1 company since 2025.

Which companies does Turtle Cameron trade?

Turtle Cameron has filed SEC Form 4 disclosures for 1 company, including SYRE.

When was Turtle Cameron's most recent SEC Form 4 filing?

Turtle Cameron's most recent SEC Form 4 filing on Tracefour is dated Oct 3, 2026.

What is Turtle Cameron's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Turtle Cameron is listed as Chief Executive Officer.

What is Turtle Cameron's total buy and sell value in the current window?

Inside the rolling retention window, Turtle Cameron bought $0 and sold $11.4M based on SEC Form 4 filings.

What was Turtle Cameron's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 15,000 SYRE shares on 2026-08-03, worth $1.4M, per SEC Form 4 filings.